The 20 Best Cholangiocarcinoma (Bile Duct Cancer) Doctors near Sugar Land, TX

Ching-wei Tzeng is a Surgical Oncologist in Houston, Texas. Dr. Tzeng is rated as an Elite provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). His top areas of expertise are Pancreatic Cancer, Cholangiocarcinoma (Bile Duct Cancer), Pancreatic Ductal Adenocarcinoma, Hepatectomy, and Pancreatectomy.

Funda Meric is a General Surgeon and a Surgical Oncologist in Houston, Texas. Dr. Meric is rated as an Elite provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). Her top areas of expertise are Breast Cancer, Cholangiocarcinoma (Bile Duct Cancer), Triple-Negative Breast Cancer, Melanoma, and Mastectomy.

Ashish Saharia is a General Surgeon and a Transplant Surgeon in Sugar Land, Texas. Dr. Saharia is rated as a Distinguished provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). His top areas of expertise are Cholangiocarcinoma (Bile Duct Cancer), Liver Failure, Hepatitis, Liver Transplant, and Hepatectomy. Dr. Saharia is currently accepting new patients in some locations.

Jean Vauthey is a Surgical Oncologist in Houston, Texas. Dr. Vauthey is rated as an Elite provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). His top areas of expertise are Cholangiocarcinoma (Bile Duct Cancer), Gallbladder Cancer, Liver Cancer, Hepatectomy, and Hepato-Pancreato-Biliary Surgery.

Dr. Benjamin Musher is a medical oncologist specializing in gastrointestinal cancers. He is the Medical Director of Medical Oncology and Director of the Gastrointestinal Cancer Program at the Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine (BCM), where he also holds the Barry Smith Endowed Professorship.Dr. Musher received an AB in Social Studies from Harvard University and his MD with Honors from BCM. He completed his residency in internal medicine at the University of Washington’s Department of Medicine, where he was an attending physician. He was later an attending physician and fellow in the Division of Hematology-Oncology at the University of Pennsylvania.Dr. Musher received the Oncology Faculty Educator of the Year for six consecutive years and the Fulbright & Jaworski L.L.P. Faculty Excellence Award, which recognizes BCM faculty for excellence in teaching and evaluation. He has also been recognized with several awards for going above and beyond to deliver exceptional patient experiences; and was named a Top Doctor in 2015 by Houstonia Magazine.Dr. Musher is board-certified in Medical Oncology from the American Board of Internal Medicine and is a member of the American Society of Clinical Oncology. Dr. Musher is rated as a Distinguished provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). His top areas of expertise are Pancreatic Cancer, Colorectal Cancer, Familial Pancreatic Cancer, and Familial Colorectal Cancer.

Chintan Shah is a Hematologist and an Oncologist in Sugar Land, Texas. Dr. Shah is rated as an Experienced provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Pleuropulmonary Blastoma, and Small Cell Lung Cancer (SCLC).

Prajnan Das is a Radiation Oncologist in Houston, Texas. Dr. Das is rated as an Advanced provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). His top areas of expertise are Stomach Cancer, Anal Cancer, Pancreatic Cancer, Pancreaticoduodenectomy, and Endoscopy.

Janet Tu is a Hematologist in Sugar Land, Texas. Dr. Tu is rated as an Experienced provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). Her top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Small Cell Lung Cancer (SCLC), and Non-Small Cell Lung Cancer (NSCLC).

Moazzam Sana is a Gastroenterologist in Sugar Land, Texas. Dr. Sana is rated as an Experienced provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). His top areas of expertise are Gastroesophageal Reflux Disease (GERD), Gas Bloat Syndrome, Familial Adenomatous Polyposis, Endoscopy, and Gastrostomy. Dr. Sana is currently accepting new patients.

Sadia Saleem is a Hematologist in Sugar Land, Texas. Dr. Saleem is rated as an Experienced provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). Her top areas of expertise are Inflammatory Breast Cancer, Breast Cancer, Paget Disease of the Breast, and Angiosarcoma.

Patrick Prath is an Oncologist in Sugar Land, Texas. Dr. Prath is rated as an Experienced provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). His top areas of expertise are Pleuropulmonary Blastoma, Lynch Syndrome, Colorectal Cancer, and Familial Colorectal Cancer. Dr. Prath is currently accepting new patients.

Jorge Darcourt is a Hematologist and an Oncologist in Sugar Land, Texas. Dr. Darcourt is rated as an Experienced provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). His top areas of expertise are Breast Cancer, Thymic Epithelial Tumor, Paget Disease of the Breast, and Prostate Cancer.

Dr. William E. Fisher is Professor and Vice-Chair for Clinical Affairs, Department of Surgery and the George L. Jordan, M.D. Chair in General Surgery at Baylor College of Medicine. Dr. Fisher also serves as Director of the Elkins Pancreas Center at BCM; and is Vice President, Medical Staff and Chief of the Surgery Service Line at Baylor St. Luke’s Medical Center.An internationally-known leader in pancreatic surgery, Dr. Fisher has focused entirely on surgery for pancreatic tumors and cysts in his practice for over 20 years and has extensive experience in advanced, minimally-invasive robotic pancreas surgery.Dr. Fisher’s professional interests include: pancreaticoduodenectomy (Whipple procedure); minimally invasive/laparoscopic/robotic pancreatic surgery; pancreas cancer; distal and central pancreatectomy; pancreas resection; surgical oncology; common bile duct resection; Puestow procedure; Frey procedure; and laparoscopic pancreatectomy.Dr. Fisher has served as PI of two NIH-funded multicenter randomized clinical trials that generated practice-changing impact on the use of drains during pancreatectomy, and the subsequent development of a multicenter pancreatic-surgery-outcomes consortium. His basic science lab has studied the influence of gastrointestinal hormones on pancreatic cancer growth, the relationship between diabetes and pancreatic cancer, and genomic analysis of pancreatic cancer, resulting in over 160 peer-reviewed publications.Having served as principal investigator on more than 15 clinical trials for patients with pancreatic cancer, Dr. Fisher is currently PI at BCM for the NIH Consortium to Study Chronic Pancreatitis, Diabetes and Pancreatic Cancer.Dr. Fisher received a B.A. from Wittenberg University and earned his medical degree from the University of Cincinnati College of Medicine.  He held a research fellowship and completed his residency at The Ohio State University.Among his numerous honors and awards, Dr. Fisher has been recognized as one of America’s Top Doctors for Cancer (Castle Connolly Medical Ltd.), Top 1% of Doctors in the U.S. (U.S. News and World Report), and “Texas Super Doctor” (Texas Monthly). He is also the recipient of the Master Clinician Award for Excellence in Patient Care from BCM and has twice received the DeBakey Distinguished Service Award from the Michael E. DeBakey Department of Surgery at BCM. Dr. Fisher is rated as an Advanced provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). His top areas of expertise are Chronic Pancreatitis, Pancreatic Cancer, Hereditary Pancreatitis, Pancreaticoduodenectomy, and Pancreatectomy.

Dr. Shalini Makawita is an oncologist specializing in gastrointestinal and general medical oncology. She is Assistant Professor of Medicine - Hematology & Oncology at the Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine.Dr. Makawita’s clinical interests include: gastrointestinal medical oncology; clinical trials; and cancer biomarkers.Dr. Makawita received a B.S. and MSc from the University of Toronto. She received her medical degree from Wayne State University School of Medicine. She completed her residency in internal medicine at Baylor College of Medicine and a fellowship in Hematology and Oncology at M.D. Anderson Cancer Center.Dr. Makawita holds certifications from the American Board of Internal Medicine in Medical Oncology and Hematology. She is a member of the American Society of Clinical Oncology and American Society of Hematology. In 2021, Dr. Makawita received the ASCO Conquer Cancer Merit Award and an Excellence in Ambulatory Care commendation in 2018 from Baylor College of Medicine. Dr. Makawita is rated as an Advanced provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). Her top areas of expertise are Triple-Negative Breast Cancer, Cholangiocarcinoma (Bile Duct Cancer), Pancreatic Cancer, and Gastrointestinal Stromal Tumor.

Eugene Koay is a Radiation Oncologist in Houston, Texas. Dr. Koay has been practicing medicine for over 17 years and is rated as a Distinguished provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). His top areas of expertise are Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Cholangiocarcinoma (Bile Duct Cancer), Pancreaticoduodenectomy, and Pancreatectomy.

Rafik Ghobrial is a Transplant Surgeon and a General Surgeon in Houston, Texas. Dr. Ghobrial is rated as a Distinguished provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). His top areas of expertise are Cholangiocarcinoma (Bile Duct Cancer), Liver Failure, Fibrolamellar Carcinoma, Liver Transplant, and Hepatectomy. Dr. Ghobrial is currently accepting new patients.

Dr. Tannaz Armaghany is Assistant Professor of Medicine-Hematology and Oncology at the Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine.Dr. Armaghany’s professional interests include: gastrointestinal medical oncology, neuroendocrine tumors, hepatocellular carcinoma, and hepatobiliary cancers.Dr. Armaghany received her medical degree from Tabriz University in Tabriz, Iran and completed her residency at Cook County Hospital in Chicago, Ill. She also completed fellowships in hematology and medical oncology at Louisiana State University Health in Shreveport, La. and integrative medicine at Arizona State University in Tucson, Ariz.Dr. Armaghany is board-certified in Medical Oncology, Hematology, and Internal Medicine from the American Board of Internal Medicine.Dr. Armaghany serves as President of the Texas branch of the Iranian American Medical Association. She is also a member of American College of Clinical Oncology, American Society of Hematology, North American Neuroendocrine Tumor Society, SWOG Cancer Research Network, Harris County Medical Society, International Society of Liver Cancer, and the Texas Medical Association. Dr. Armaghany is rated as an Experienced provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). Her top areas of expertise are Neuroendocrine Tumor, Fibrolamellar Carcinoma, Gallbladder Adenocarcinoma, and Gallbladder Cancer.

Dr. Omar Barakat is a general surgeon specializing in benign and malignant diseases of the liver, bile duct, gallbladder, and pancreas. He is an Associate Professor of Surgery - Division of Surgical Oncology at Baylor College of Medicine and Medical Director of the Neuroendocrine Tumor Program at Baylor St. Luke’s Medical Center.Dr. Barakat’s clinical interests include: malignant hepatobiliary and pancreatic diseases, liver and pancreas surgery; upper gastrointestinal surgery; neuroendocrine tumors; gastrointestinal stromal tumors (GIST); and minimally invasive surgery.Dr. Barakat has developed new surgical techniques to minimize the complication rate and blood loss following pancreatic and liver surgeries. He utilizes image-guided therapies, such as radiofrequency ablation, microwave ablation, irreversible electroporation (NanoKnife system), trans-arterial chemotherapy, and selective internal radiotherapy (SIRT) with Yttrium-90 microspheres, to treat liver tumors while minimizing trauma to the patients. Dr. Barakat's clinical and research interests also include the study of neuroendocrine tumors; and the development of off-the-shelf bio-artificial liver organs that can be suitable for liver transplantation in patients with end-stage liver disease.Dr. Barakat received his medical degree from Aleppo University Medical School in Aleppo, Syria. He completed a residency in general surgery at the Medical College of Pennsylvania, Episcopal Hospital in Philadelphia and a Fellowship in cardiovascular surgery research at State University of New York - Buffalo. He also completed clinical fellowships in liver transplantation at The University of Texas Health Science Center in Houston; and in heart transplantation and mechanical assist devices aat the Texas Heart Institute. He continued his practice in liver and pancreatic surgery at Freeman Hospital in Newcastle Upon-Tyne, United Kingdom, where he treated complex and rare tumors of the liver, bile duct, and pancreas. Dr. Barakat is board-certified by the Royal College of Surgeons (Ed), United Kingdom, where he is also a Fellow. Dr. Barakat is rated as an Experienced provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). His top areas of expertise are Chronic Pancreatitis, Gallbladder Disease, Pancreatic Cancer, Pancreaticoduodenectomy, and Pancreatectomy.

Dr. E. Ramsay Camp is Professor and Chief of the Division of Surgical Oncology in the Michael E. DeBakey Department of Surgery at Baylor College of Medicine.Dr. Camp’s clinical practice and expertise has focused on treating patients with complex tumors of the gastrointestinal system, including pancreatic and gastric malignancies, as well as sarcoma and melanoma. His professional interests include surgical oncology, pancreatic cancer, pancreaticobiliary malignancies, gastric cancer, sarcoma, melanoma, small bowel tumors, neuroendocrine tumors, gastrointestinal tumors, minimally invasive surgery, and hyperthermic intraperitoneal chemotherapy (HIPEC).Dr. Camp earned a B.A. in Chemistry from Davidson College and received his medical degree from the Medical University of South Carolina. He completed his general surgery training at Shand's Hospital at the University of Florida and finished a surgical oncology fellowship at the University of Texas M.D. Anderson Cancer Center.Following 12 years in practice at the Medical University of South Carolina, Dr. Camp joined the faculty of Baylor as the Chief of Surgical Oncology. He has an active, externally-funded research laboratory supported by a VA Merit Award, focusing on mechanisms of chemotherapy and radiation resistance in pancreatic and colorectal cancer.Dr. Camp is a fellow of the American College of Surgeons and a member of various oncology societies, including the American Surgical Association, the Southern Surgical Association, Society of Surgical Oncology, American Society of Clinical Oncology, American Association of Cancer Research, National Surgical Adjuvant Bowel Project, Southwest Oncology Group, and the American College of Surgeons Oncology Group.Professional Interests:Surgical oncologyPancreatic cancerPancreaticobiliary malignanciesGastric cancer and other gastric malignanciesSarcomaMelanomaSmall bowel tumorsNeuroendocrine tumorsGasrointestinal tumorsMinimally invasive surgeryHIPEC. Dr. Camp is rated as an Experienced provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). His top areas of expertise are Stomach Cancer, Melanoma, Pancreatic Cancer, Pancreatectomy, and Small Bowel Resection.

George Van Buren, II, M.D. is an associate professor of surgery in the Division of Surgical Oncology of the Michael E. DeBakey Department of Surgery at Baylor College of Medicine. Dr. Van Buren is a board-certified surgeon specializing surgical oncology and pancreatic disorders.A native Houstonian, Dr. Van Buren earned his undergraduate degree at the University of Texas at Austin and his medical degree at the University of Texas Medical School at Houston. He completed his general surgery residency at the University of Texas Medical School at Houston. During that time period, he spent two years at MD Anderson Cancer Center as an NIH T32 research fellow studying pancreatic cancer and neuroendocrine tumors. He completed his surgical oncology fellowship at the University of Pittsburgh Medical Center in the Translational Pancreas Research Track.During Dr. Van Buren’s research and clinical fellowships, he was able to expand upon his interest in gastrointestinal surgical oncology and pancreatic disorders. Specifically, his training had a heavy emphasis on pancreatic and gastric malignancies with exposure to wide breadth of cases, including specialized procedures such as robotic pancreatic surgery.Dr. Van Buren is active in both patient care and research. He has spent over 15 years in training and in practice focusing on care for patients with pancreatic and gastrointestinal malignancies. He is involved in both basic science and clinical research and believes heavily in the surgeon’s role as a leader of the translational research team. His goals are to provide high quality clinical care while offering his patients access to innovative clinical and therapeutic trials. He is a member of the Elkins Pancreas Center and Dan L. Duncan NCI Cancer Center at Baylor College of Medicine. Dr. Van Buren is rated as an Experienced provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). His top areas of expertise are Pancreatic Cancer, Gallbladder Adenocarcinoma, Gallbladder Cancer, Splenectomy, and Pancreatectomy.